RhumbLine Advisers
GEN

RhumbLine Advisers’s Genesis Healthcare, Inc. GEN Stock Holding History

RhumbLine Advisers’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-113,532
Closed -$96K – 3155
2020
Q1 		$96K Hold
113,532
– – ﹤0.01% 2788
2019
Q4 		$186K Buy
113,532
+5,536
+5% +$8.31K ﹤0.01% 2771
2019
Q3 		$120K Sell
107,996
-160
-0.1% -$185 ﹤0.01% 2857
2019
Q2 		$134K Buy
108,156
+41,294
+62% +$52.6K ﹤0.01% 2879
2019
Q1 		$96K Sell
66,862
-1,435
-2% -$2.13K ﹤0.01% 2865
2018
Q4 		$81K Buy
68,297
+23,160
+51% +$34.4K ﹤0.01% 2903
2018
Q3 		$61K Sell
45,137
-3,275
-7% -$5.19K ﹤0.01% 2900
2018
Q2 		$111K Buy
48,412
+15,100
+45% +$29.2K ﹤0.01% 2861
2018
Q1 		$50K Sell
33,312
-100
-0.3% -$117 ﹤0.01% 2793
2017
Q4 		$25K Sell
33,412
-30,664
-48% -$27.4K ﹤0.01% 2827
2017
Q3 		$74K Buy
64,076
+2,761
+5% +$3.48K ﹤0.01% 2878
2017
Q2 		$107K Sell
61,315
-2,553
-4% -$5.42K ﹤0.01% 2889
2017
Q1 		$169K Buy
63,868
+22,523
+54% +$80.9K ﹤0.01% 2692
2016
Q4 		$176K Sell
41,345
-17,186
-29% -$56.7K ﹤0.01% 2702
2016
Q3 		$156K Buy
58,531
+26,800
+84% +$61.6K ﹤0.01% 2747
2016
Q2 		$56K Sell
31,731
-17,765
-36% -$36.2K ﹤0.01% 2960
2016
Q1 		$115K Buy
49,496
+2,645
+6% +$5.98K ﹤0.01% 2868
2015
Q4 		$163K Buy
46,851
+6,330
+16% +$30.3K ﹤0.01% 2861
2015
Q3 		$248K Buy
40,521
+1,973
+5% +$13.4K ﹤0.01% 2664
2015
Q2 		$254K Buy
38,548
+9,065
+31% +$61.1K ﹤0.01% 2760
2015
Q1 		$210K Buy
+29,483
New +$222K ﹤0.01% 2817

Other funds holding GEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RhumbLine Advisers's GEN Position: Q2 2020 in Review

RhumbLine Advisers sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 113,532 shares — an estimated $96K sold.

RhumbLine Advisers first reported a position in GEN in Q1 2015 and held it in 21 quarters. The position peaked at $254K in Q2 2015. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

  • RhumbLine Advisers reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
  • RhumbLine Advisers sold 113,532 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $96K.
  • RhumbLine Advisers first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 21 quarters.
  • RhumbLine Advisers's Genesis Healthcare, Inc. position peaked at $254K in Q2 2015.
  • 58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.